PureTech Health plc (PRTC)
PureTech Health plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
PureTech Health plc (PRTC) is a Biotechnology company based in US with a market capitalization of $423.1M. Revenue declined 3.5% year-over-year and free cash flow was negative at -$85.3M. This page tracks PRTC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 80 employees · IPO Nov 16, 2020
Valuation
Valuation & price
$17.39as of May 17, 2026· -12.3% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.36
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$423.1M
Market cap
-3.5%
Revenue growth (YoY)
100.0%
Gross margin
-$85.3M
Free cash flow (USD)
-$259.1M
Net debt
Net cash position
-91.1%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is PureTech Health plc's market cap?
PureTech Health plc (PRTC) has a market capitalization of $423.1M.
What is PRTC's P/E ratio?
A meaningful P/E ratio is not available for PRTC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is PRTC's price-to-book (P/B) ratio?
PRTC trades at 1.36 times book value per share.
Are insiders buying PRTC stock?
SEC Form 4 filings show no open-market insider buys at PureTech Health plc in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.